These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27068827)

  • 21. Intraocular Light Scatter in Eyes With the Boston Type 1 Keratoprosthesis.
    Karas FI; Arteaga A; Barrionuevo P; Cao D; McAnany JJ; Shorter E; Cortina MS
    Cornea; 2019 Jan; 38(1):50-53. PubMed ID: 30157051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of outcomes in patients with and without soft contact lens wear following Boston keratoprosthesis type 1.
    Liu J; Harissi-Dagher M
    Can J Ophthalmol; 2022 Jun; 57(3):154-160. PubMed ID: 34058143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratoprosthesis: procedure of choice for corneal opacities in children?
    Nallasamy S; Colby K
    Semin Ophthalmol; 2010; 25(5-6):244-8. PubMed ID: 21091007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Utility of soft hydrogel contact lenses in case of epithelial defects after corneal grafts (19) (author's transl)].
    Gosselin C; Kreis-Gosselin F; Pouliquen Y
    J Fr Ophtalmol; 1978 Oct; 1(10):583-7. PubMed ID: 153355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insertion of a bandage contact lens with Minims.
    Ahmad R; Manjunatha NP; Nag P; Desai SP
    Eye Contact Lens; 2007 Mar; 33(2):89-90. PubMed ID: 17496701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Boston keratoprosthesis type 1].
    Harissi-Dagher M; Slim E
    J Fr Ophtalmol; 2019 Mar; 42(3):295-302. PubMed ID: 30857801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
    Pujari S; Siddique SS; Dohlman CH; Chodosh J
    Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic use of Bausch & Lomb PureVision contact lenses.
    Lim L; Tan DT; Chan WK
    CLAO J; 2001 Oct; 27(4):179-85. PubMed ID: 11725978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiological Evaluation of Bandage Soft Contact Lenses Used in Management of Persistent Corneal Epithelial Defects.
    Feizi S; Masoudi A; Hosseini SB; Kanavi MR; Javadi MA
    Cornea; 2019 Feb; 38(2):146-150. PubMed ID: 30422865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trichosporon asahii keratitis in a patient with a type I Boston keratoprosthesis and contact lens.
    Keating A; Pineda R
    Eye Contact Lens; 2012 Mar; 38(2):130-2. PubMed ID: 21876439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of precut, γ-irradiated corneal lenticules in Boston type 1 keratoprosthesis implantation.
    Akpek EK; Aldave AJ; Aquavella JV
    Am J Ophthalmol; 2012 Sep; 154(3):495-498.e1. PubMed ID: 22633353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
    Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Boston keratoprosthesis provides a wide depth of focus.
    Sayegh RR; Dohlman CH; Greenstein SH; Peli E
    Ophthalmic Physiol Opt; 2015 Jan; 35(1):39-44. PubMed ID: 25424372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Apr; 31(4):346-9. PubMed ID: 22314825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Situ Corneal Cross-Linking for Recurrent Corneal Melting After Boston Type 1 Keratoprosthesis.
    Tóth G; Bucher F; Siebelmann S; Bachmann B; Hermann M; Szentmáry N; Nagy ZZ; Cursiefen C
    Cornea; 2016 Jun; 35(6):884-7. PubMed ID: 27032020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contact lens surveillance cultures in Boston type 1 keratoprosthesis patients.
    Rai R; Shorter E; Cortina MS; McMahon T; de la Cruz J
    Eye Contact Lens; 2013 Mar; 39(2):175-8. PubMed ID: 23392305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contact lens fitting and long-term management for the Boston keratoprosthesis.
    Nau AC; Drexler S; Dhaliwal DK; Mah F; Raju L; Deschler E
    Eye Contact Lens; 2014 May; 40(3):185-9. PubMed ID: 24508771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.